# Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years

Study · id `cardio:ct-nct05373940` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05373940](<https://clinicaltrials.gov/study/NCT05373940>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05373940

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 730 participants.

## Technical summary

Registry record NCT05373940. Randomized; single masking; primary purpose prevention. Start 2022-06-29 (actual); primary completion 2030-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 730 participants (planned count; ClinicalTrials.gov record NCT05373940, source copy `cardio:ctgov-nct05373940-2026-03-24`, retrieved 2026-10-26)
- Started: 2022-06-29 (actual) (ClinicalTrials.gov record NCT05373940, source copy `cardio:ctgov-nct05373940-2026-03-24`, retrieved 2026-10-26)
- Primary completion: 2030-05-31 (anticipated) (ClinicalTrials.gov record NCT05373940, source copy `cardio:ctgov-nct05373940-2026-03-24`, retrieved 2026-10-26)
- Completion: 2030-05-31 (anticipated) (ClinicalTrials.gov record NCT05373940, source copy `cardio:ctgov-nct05373940-2026-03-24`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT05373940, source copy `cardio:ctgov-nct05373940-2026-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05373940-2026-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years
- Acronym: DILEMMA
- Condition: Heart Failure
- Condition: Primary Prevention of Sudden Cardiac Death
- Condition: Implantable Cardioverter Defibrillator
- Intervention (Device): ICD implantation
- Intervention (Device): No ICD implantation
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, France
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)
- Registry lists this organization as a collaborator: Ministry of Health, France (`cardio:org-ministry-of-health-france`)

## Provenance

Content hash: 1880f6b28752b3176d425f3ac54c822ea1ffb36bf4a5a3b33e7d64f091b0c943
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
